David C. Harmon
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Rheumatology top 1%
- Bone Tumor Diagnosis and Treatments
- Soft tissue tumor case studies
Papers in
-
- Sarcoma Diagnosis and Treatment 61
- Rheumatology 12
- Bone Tumor Diagnosis and Treatments 8
- Soft tissue tumor case studies 3
- Co-authors
- Francis John Hornicek (53 shared papers)Henry J. Mankin (38 shared papers)Edwin Choy (42 shared papers)Thomas F. DeLaney (34 shared papers)Herman D. Suit (13 shared papers)Andrew Eric Rosenberg (17 shared papers)Zhenfeng Duan (17 shared papers)G. Petur Nielsen (15 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (14 papers)Cancer (13 papers)Journal of Clinical Oncology (8 papers)Annals of Surgical Oncology (5 papers)The Oncologist (5 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
David C. Harmon
111 papers receiving 7.4k citations
David C. Harmon's Hit Papers
Peers
Comparison fields: 5 of 93
- Pulmonary and Respiratory Medicine 4.1k
- Rheumatology 810
- Oncology 873
- Cancer Research 406
- Hematology 324
Countries citing papers authored by David C. Harmon
This map shows the geographic impact of David C. Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Harmon more than expected).
Fields of papers citing papers by David C. Harmon
This network shows the impact of papers produced by David C. Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Harmon. The network helps show where David C. Harmon may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Harmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002 Hit paper breakdown → | 2007 | 608 |
| 2 | 2009 | 276 | |
| 3 | 2004 | 265 | |
| 4 | 2003 | 253 | |
| 5 | 2007 | 230 | |
| 6 | 1988 | 226 | |
| 7 | 2008 | 222 | |
| 8 | 2006 | 220 | |
| 9 | 2011 | 208 | |
| 10 | 2014 | 196 | |
| 11 | 2005 | 166 | |
| 12 | 2014 | 164 | |
| 13 | 2004 | 152 | |
| 14 | 2007 | 145 | |
| 15 | 2011 | 145 | |
| 16 | 2014 | 134 | |
| 17 | 1988 | 115 | |
| 18 | 2012 | 112 | |
| 19 | 1984 | 111 | |
| 20 | 1988 | 111 |
About David C. Harmon
David C. Harmon is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Oncology, Hematology and Pathology and Forensic Medicine, having authored 114 papers that have together received 7.8k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (61 papers), Bone Tumor Diagnosis and Treatments (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Blood disorders and treatments (4 papers), MicroRNA in disease regulation (3 papers), Soft tissue tumor case studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.1k citations), Rheumatology (810 citations), Oncology (873 citations), Cancer Research (406 citations) and Hematology (324 citations). David C. Harmon has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Francis John Hornicek, Henry J. Mankin, Edwin Choy, Thomas F. DeLaney, Herman D. Suit, Andrew Eric Rosenberg, Zhenfeng Duan, G. Petur Nielsen, Robert G. Maki and Mark C. Gebhardt. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer, Journal of Clinical Oncology, Annals of Surgical Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.